Correlation between expression of hypoxia-factor-1αmRNA and angiogenesis in gastric adenocarcinoma

World Chinese Journal of Digestology

Volumn 10, Issue 6, 2002, Pages 633-637

  Zhang, Yan Min ^a   Deng, Chang Sheng ^a   Zhu, You Qing ^a   Mao, Yong Rong ^a   Zhang, Ke ^a   Yang, Yuan Pin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER STAGING; CLINICAL RESEARCH; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA;

EID: 0036308090     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1
2. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
3. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
4. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
5. Induction of vascular endothelial growth factor by hypoxia is mudulated by a phosphatidylinositl 3-kinase/Akt sigaling pathway in Ha-ras transformed cells through a hypoxia inducible facotr-1 transcriptional element
6. V-SRC induces expression of hypoxia-inducible facotr 1 (HIF-1) and transcription of HIF-1 in tumor progression
7. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha→hypoxia response element→VEGF cascade differentially regulates vascular response and growth rate in tumors
8. Hypoxia-inducible factor-1αis a marker foran unfavorable prognosis in early stage invasive cervical cancer
9. Angiogenesis and apoptosis in human hepatocellular carcinoma
10. Gastric carcinogenesis and reactivity of microvessel induced by N-methl-N′-nitro-N-nitrosoguanidine (MNNG) in rats
11. Correlations of microvessel quantitation in colorectal tumors and clinicopathology
12. The expression of platelet-derived growth factor and angiogenesis in human colorectal carcinoma
13. Effect of vascular endothelial growth factor on adhesion of large intestine cancer cell HT-29
14. 4 in rats
15. The detection of vasculendothelium growth factor expression and the apoptosis index
16. The distrbution, quantum and significance of vascular endothelium growth factor and its receptor in large intestine cancer
17. Relationship between proliferation of vascular andothelial cells and gastric cancer
18. Relationship between microvessel density and proliferating cell nuclear antigen and prognosis in colorectal cancer
19. Interactions between human gastric carcinoma cells and vascular endothelial cells
20. The molecul mechanism of malignant conversion induced by hypoxia
21. The tumor angiogenesis and the anti-therapeutics on it
22. The clinical significance of the microvessel density of carcinoma of gallbladder
23. 2 homeostasis by hypoxia-inducible factor 1
24. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth
25. De Marzo overexpression of hypoxia-inducible factor 1 in common human cancers and their metastases1
26. Level of hypoxia-inducible factor-1αduring breast carcinogenesis
27. Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression
28. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer
29. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors
30. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts
31. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1
32. Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy
33. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway
34. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis
35. Constitutive expression of hypoxia-induciblefactor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation
36. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α 1alpha
37. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha
38. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer
39. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism
40. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis